HIMS Hims & Hers Health, Inc.

NYSE Services-Offices & Clinics of Doctors of Medicine DE CIK: 0001773751
AI RATING
HOLD
65% Confidence

Investment Thesis

Hims demonstrates impressive 59% revenue growth and maintains a fortress balance sheet with $222.3M cash, zero debt, and positive free cash flow of $53.1M. However, operating losses of $78.3M and negative ROE of -20.6% reflect deteriorating unit economics and unclear path to profitability, requiring proof of operating leverage before upgrading thesis.

Strengths

  • + Exceptional 59% YoY revenue growth with 65.2% gross margins indicating strong pricing power
  • + Positive free cash flow of $53.1M and operating cash flow of $89.4M despite net losses
  • + Fortress balance sheet with zero long-term debt, $222.3M cash, and 1.69x current ratio

Risks

  • ! Company unprofitable with -$92.1M net loss and -12.9% operating margin indicating unsustainable cost structure
  • ! Negative returns: ROE of -20.6% and ROA of -4.1% suggest shareholder value destruction at current scale
  • ! Operating expenses consuming 78.1% of revenue despite high gross margins indicates lack of operating leverage

Key Metrics to Watch

Financial Metrics

Revenue
608.1M
Net Income
-92.1M
EPS (Diluted)
$-0.40
Free Cash Flow
53.1M
Total Assets
2.3B
Cash
222.3M

Profitability Ratios

Gross Margin 65.2%
Operating Margin -12.9%
Net Margin -15.1%
ROE -20.6%
ROA -4.1%
FCF Margin 8.7%

Balance Sheet & Liquidity

Current Ratio
1.69x
Quick Ratio
1.56x
Debt/Equity
0.00x
Debt/Assets
80.3%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-13T08:35:48.672433 | Data as of: 2026-03-31 | Powered by Claude AI